<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35487695</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">2575-1077</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>5</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Life science alliance</Title>
          <ISOAbbreviation>Life Sci Alliance</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e202101337</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.26508/lsa.202101337</ELocationID>
        <Abstract>
          <AbstractText>Radiation therapy generates extensive cancer cell death capable of promoting tumor-specific immunity. Within the tumor, conventional dendritic cells (cDCs) are known to carry tumor-associated antigens to the draining lymph node (TdLN) where they initiate T-cell priming. How radiation influences cDC migration is poorly understood. Here, we show that immunological efficacy of radiation therapy is dependent on cDC migration in radioimmunogenic tumors. Using photoconvertible mice, we demonstrate that radiation impairs cDC migration to the TdLN in poorly radioimmunogenic tumors. Comparative transcriptional analysis revealed that cDCs in radioimmunogenic tumors express genes associated with activation of endogenous adjuvant signaling pathways when compared with poorly radioimmunogenic tumors. Moreover, an exogenous adjuvant combined with radiation increased the number of migrating cDCs in these poorly radioimmunogenic tumors. Taken together, our data demonstrate that cDC migration play a critical role in the response to radiation therapy.</AbstractText>
          <CopyrightInformation>© 2022 Blair et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Blair</LastName>
            <ForeName>Tiffany C</ForeName>
            <Initials>TC</Initials>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bambina</LastName>
            <ForeName>Shelly</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kramer</LastName>
            <ForeName>Gwen F</ForeName>
            <Initials>GF</Initials>
            <Identifier Source="ORCID">0000-0002-5362-5181</Identifier>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dowdell</LastName>
            <ForeName>Alexa K</ForeName>
            <Initials>AK</Initials>
            <Identifier Source="ORCID">0000-0003-4866-6293</Identifier>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alice</LastName>
            <ForeName>Alejandro F</ForeName>
            <Initials>AF</Initials>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baird</LastName>
            <ForeName>Jason R</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lund</LastName>
            <ForeName>Amanda W</ForeName>
            <Initials>AW</Initials>
            <Identifier Source="ORCID">0000-0001-7389-9983</Identifier>
            <AffiliationInfo>
              <Affiliation>Ronald O Perelman Department of Dermatology, Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Piening</LastName>
            <ForeName>Brian D</ForeName>
            <Initials>BD</Initials>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crittenden</LastName>
            <ForeName>Marka R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Oregon Clinic, Portland, OR, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gough</LastName>
            <ForeName>Michael J</ForeName>
            <Initials>MJ</Initials>
            <Identifier Source="ORCID">0000-0002-5575-0074</Identifier>
            <AffiliationInfo>
              <Affiliation>Earle A Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA michael.gough@providence.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Life Sci Alliance</MedlineTA>
        <NlmUniqueID>101728869</NlmUniqueID>
        <ISSNLinking>2575-1077</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003713" MajorTopicYN="Y">Dendritic Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008198" MajorTopicYN="Y">Lymph Nodes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors receive research funding from Bristol Myers Squibb and VIR Biotechnology and consulting fees from Roche that is not directly related to the topic of this manuscript. Funders had no role in the representation of the data or the preparation of the manuscript.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>21</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35487695</ArticleId>
        <ArticleId IdType="pmc">PMC9058260</ArticleId>
        <ArticleId IdType="doi">10.26508/lsa.202101337</ArticleId>
        <ArticleId IdType="pii">5/9/e202101337</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gerweck LE, Vijayappa S, Kurimasa A, Ogawa K, Chen DJ (2006) Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Res
66: 8352–8355. 10.1158/0008-5472.CAN-06-0533</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-0533</ArticleId>
            <ArticleId IdType="pubmed">16951142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil B, Malaise EP (1985) Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys
11: 1699–1707. 10.1016/0360-3016(85)90223-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0360-3016(85)90223-8</ArticleId>
            <ArticleId IdType="pubmed">4030437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jonathan EC, Bernhard EJ, McKenna WG (1999) How does radiation kill cells?
Curr Opin Chem Biol
3: 77–83. 10.1016/s1367-5931(99)80014-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1367-5931(99)80014-3</ArticleId>
            <ArticleId IdType="pubmed">10021401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, Beckett M, Sharma R, Chin R, Tu T, et al.  (2009) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment. Blood
114: 589–595. 10.1182/blood-2009-02-206870</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-02-206870</ArticleId>
            <ArticleId IdType="pmc">PMC2713472</ArticleId>
            <ArticleId IdType="pubmed">19349616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al.  (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med
13: 1050–1059. 10.1038/nm1622</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1622</ArticleId>
            <ArticleId IdType="pubmed">17704786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crittenden MR, Zebertavage L, Kramer G, Bambina S, Friedman D, Troesch V, Blair T, Baird JR, Alice A, Gough MJ (2018) Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity. Sci Rep
8: 7012. 10.1038/s41598-018-25482-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-25482-w</ArticleId>
            <ArticleId IdType="pmc">PMC5934473</ArticleId>
            <ArticleId IdType="pubmed">29725089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, et al.  (2008) Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science
322: 1097–1100. 10.1126/science.1164206</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1164206</ArticleId>
            <ArticleId IdType="pmc">PMC2756611</ArticleId>
            <ArticleId IdType="pubmed">19008445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anandasabapathy N, Feder R, Mollah S, Tse SW, Longhi MP, Mehandru S, Matos I, Cheong C, Ruane D, Brane L, et al.  (2014) Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J Exp Med
211: 1875–1891. 10.1084/jem.20131397</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20131397</ArticleId>
            <ArticleId IdType="pmc">PMC4144735</ArticleId>
            <ArticleId IdType="pubmed">25135299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, Klekotka PA, Moon C, Albring JC, Ise W, Michael DG, et al.  (2010) Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med
207: 823–836. 10.1084/jem.20091627</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20091627</ArticleId>
            <ArticleId IdType="pmc">PMC2856032</ArticleId>
            <ArticleId IdType="pubmed">20351058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, Pandey G, Leboeuf M, Elpek KG, Helft J, et al.  (2012) Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol
13: 888–899. 10.1038/ni.2370</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.2370</ArticleId>
            <ArticleId IdType="pmc">PMC3985403</ArticleId>
            <ArticleId IdType="pubmed">22797772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitano M, Yamazaki C, Takumi A, Ikeno T, Hemmi H, Takahashi N, Shimizu K, Fraser SE, Hoshino K, Kaisho T, et al.  (2016) Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node. Proc Natl Acad Sci U S A
113: 1044–1049. 10.1073/pnas.1513607113</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1513607113</ArticleId>
            <ArticleId IdType="pmc">PMC4743831</ArticleId>
            <ArticleId IdType="pubmed">26755602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, Kaisho T, Bogunovic D, Bhardwaj N, Krummel MF (2016) Critical role for CD103(+)/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell
30: 324–336. 10.1016/j.ccell.2016.06.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2016.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC5374862</ArticleId>
            <ArticleId IdType="pubmed">27424807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golden EB, Frances D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti SC (2014) Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology
3: e28518. 10.4161/onci.28518</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/onci.28518</ArticleId>
            <ArticleId IdType="pmc">PMC4106151</ArticleId>
            <ArticleId IdType="pubmed">25071979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filatenkov A, Baker J, Mueller AM, Kenkel J, Ahn GO, Dutt S, Zhang N, Kohrt H, Jensen K, Dejbakhsh-Jones S, et al.  (2015) Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions. Clin Cancer Res
21: 3727–3739. 10.1158/1078-0432.CCR-14-2824</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-14-2824</ArticleId>
            <ArticleId IdType="pmc">PMC4537844</ArticleId>
            <ArticleId IdType="pubmed">25869387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S (2017) DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun
8: 15618. 10.1038/ncomms15618</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms15618</ArticleId>
            <ArticleId IdType="pmc">PMC5472757</ArticleId>
            <ArticleId IdType="pubmed">28598415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medler TR, Blair TC, Crittenden MR, Gough MJ (2021) Defining immunogenic and radioimmunogenic tumors. Front Oncol
11: 667075. 10.3389/fonc.2021.667075</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2021.667075</ArticleId>
            <ArticleId IdType="pmc">PMC8017281</ArticleId>
            <ArticleId IdType="pubmed">33816320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blair TC, Bambina S, Alice AF, Kramer GF, Medler TR, Baird JR, Broz ML, Tormoen GW, Troesch V, Crittenden MR, et al.  (2020) Dendritic cell maturation defines immunological responsiveness of tumors to radiation therapy. J Immunol
204: 3416–3424. 10.4049/jimmunol.2000194</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.2000194</ArticleId>
            <ArticleId IdType="pmc">PMC7571541</ArticleId>
            <ArticleId IdType="pubmed">32341058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dovedi SJ, Lipowska-Bhalla G, Beers SA, Cheadle EJ, Mu L, Glennie MJ, Illidge TM, Honeychurch J (2016) Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CD8+ T cells. Cancer Immunol Res
4: 621–630. 10.1158/2326-6066.CIR-15-0253</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/2326-6066.CIR-15-0253</ArticleId>
            <ArticleId IdType="pmc">PMC5348028</ArticleId>
            <ArticleId IdType="pubmed">27241845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blair TC, Alice AF, Zebertavage L, Crittenden MR, Gough MJ (2021) The dynamic entropy of tumor immune infiltrates: The impact of recirculation, antigen-specific interactions, and retention on T cells in tumors. Front Oncol
11: 653625. 10.3389/fonc.2021.653625</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2021.653625</ArticleId>
            <ArticleId IdType="pmc">PMC8101411</ArticleId>
            <ArticleId IdType="pubmed">33968757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zebertavage LK, Alice A, Crittenden MR, Gough MJ (2020) Transcriptional upregulation of NLRC5 by radiation drives STING- and interferon-independent MHC-I expression on cancer cells and T cell cytotoxicity. Sci Rep
10: 7376. 10.1038/s41598-020-64408-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-64408-3</ArticleId>
            <ArticleId IdType="pmc">PMC7193601</ArticleId>
            <ArticleId IdType="pubmed">32355214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, et al.  (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med
203: 1259–1271. 10.1084/jem.20052494</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20052494</ArticleId>
            <ArticleId IdType="pmc">PMC3212727</ArticleId>
            <ArticleId IdType="pubmed">16636135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dovedi SJ, Cheadle EJ, Popple AL, Poon E, Morrow M, Stewart R, Yusko EC, Sanders CM, Vignali M, Emerson RO, et al.  (2017) Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade. Clin Cancer Res
23: 5514–5526. 10.1158/1078-0432.CCR-16-1673</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-16-1673</ArticleId>
            <ArticleId IdType="pubmed">28533222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, et al.  (2018) Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy. Clin Cancer Res
24: 5058–5071. 10.1158/1078-0432.CCR-17-3427</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-17-3427</ArticleId>
            <ArticleId IdType="pmc">PMC6532976</ArticleId>
            <ArticleId IdType="pubmed">29898992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrell MI, Iritani BM, Ruddell A (2008) Lymph node mapping in the mouse. J Immunol Methods
332: 170–174. 10.1016/j.jim.2007.11.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jim.2007.11.012</ArticleId>
            <ArticleId IdType="pmc">PMC2342937</ArticleId>
            <ArticleId IdType="pubmed">18164026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Procissi D, Li W, Kim DH, Li K, Han G, Huan Y, Larson AC (2013) High resolution MRI for non-invasive mouse lymph node mapping. J Immunol Methods
400-401: 23–29. 10.1016/j.jim.2013.06.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jim.2013.06.013</ArticleId>
            <ArticleId IdType="pmc">PMC3855564</ArticleId>
            <ArticleId IdType="pubmed">23850992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomura M, Yoshida N, Tanaka J, Karasawa S, Miwa Y, Miyawaki A, Kanagawa O (2008) Monitoring cellular movement in vivo with photoconvertible fluorescence protein [L8D2Q2M0]Kaede[R8D2Q2M1] transgenic mice. Proc Natl Acad Sci U S A
105: 10871–10876. 10.1073/pnas.0802278105</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0802278105</ArticleId>
            <ArticleId IdType="pmc">PMC2504797</ArticleId>
            <ArticleId IdType="pubmed">18663225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torcellan T, Hampton HR, Bailey J, Tomura M, Brink R, Chtanova T (2017) In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci U S A
114: 5677–5682. 10.1073/pnas.1618446114</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1618446114</ArticleId>
            <ArticleId IdType="pmc">PMC5465915</ArticleId>
            <ArticleId IdType="pubmed">28507145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steele MM, Churchill MJ, Breazeale AP, Lane RS, Nelson NA, Lund AW (2019) Quantifying leukocyte egress via lymphatic vessels from murine skin and tumors. J Vis Exp
10.3791/58704</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3791/58704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaplan DH (2017) Ontogeny and function of murine epidermal Langerhans cells. Nat Immunol
18: 1068–1075. 10.1038/ni.3815</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3815</ArticleId>
            <ArticleId IdType="pmc">PMC6422157</ArticleId>
            <ArticleId IdType="pubmed">28926543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol
31: 563–604. 10.1146/annurev-immunol-020711-074950</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-immunol-020711-074950</ArticleId>
            <ArticleId IdType="pmc">PMC3853342</ArticleId>
            <ArticleId IdType="pubmed">23516985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, et al.  (1994) The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med
180: 1849–1860. 10.1084/jem.180.5.1849</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.180.5.1849</ArticleId>
            <ArticleId IdType="pmc">PMC2191729</ArticleId>
            <ArticleId IdType="pubmed">7525841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, Chudnovskiy A, Maskey S, Walker L, Finnigan JP, et al.  (2020) A conserved dendritic-cell regulatory program limits antitumour immunity. Nature
580: 257–262. 10.1038/s41586-020-2134-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2134-y</ArticleId>
            <ArticleId IdType="pmc">PMC7787191</ArticleId>
            <ArticleId IdType="pubmed">32269339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, Blankenstein T, Henning G, Förster R (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity
21: 279–288. 10.1016/j.immuni.2004.06.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2004.06.014</ArticleId>
            <ArticleId IdType="pubmed">15308107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Müller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell
99: 23–33. 10.1016/s0092-8674(00)80059-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(00)80059-8</ArticleId>
            <ArticleId IdType="pubmed">10520991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharon S, Baird JR, Bambina S, Kramer G, Blair TC, Jensen SM, Leidner RS, Bell RB, Casap N, Crittenden MR, et al.  (2021) A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection. Oncotarget
12: 1201–1213. 10.18632/oncotarget.27982</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.27982</ArticleId>
            <ArticleId IdType="pmc">PMC8238246</ArticleId>
            <ArticleId IdType="pubmed">34194619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baird JR, Bell RB, Troesch V, Friedman D, Bambina S, Kramer G, Blair TC, Medler T, Wu Y, Sun Z, et al.  (2018) Evaluation of explant responses to STING ligands: Personalized immunosurgical therapy for head and neck squamous cell carcinoma. Cancer Res
78: 6308–6319. 10.1158/0008-5472.CAN-18-1652</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-18-1652</ArticleId>
            <ArticleId IdType="pubmed">30224374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P, et al.  (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell
184: 792–809.e23. 10.1016/j.cell.2021.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2021.01.010</ArticleId>
            <ArticleId IdType="pubmed">33545035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jakob B, Scholz M, Taucher-Scholz G (2000) Immediate localized CDKN1A (p21) radiation response after damage produced by heavy-ion tracks. Radiat Res
154: 398–405. 10.1667/0033-7587(2000)154[0398:ilcprr]2.0.co;2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1667/0033-7587(2000)154[0398:ilcprr]2.0.co;2</ArticleId>
            <ArticleId IdType="pubmed">11023603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price JG, Idoyaga J, Salmon H, Hogstad B, Bigarella CL, Ghaffari S, Leboeuf M, Merad M (2015) CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation. Nat Immunol
16: 1060–1068. 10.1038/ni.3270</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3270</ArticleId>
            <ArticleId IdType="pmc">PMC4620552</ArticleId>
            <ArticleId IdType="pubmed">26343536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ning S, Pagano JS, Barber GN (2011) IRF7: Activation, regulation, modification and function. Genes Immun
12: 399–414. 10.1038/gene.2011.21</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gene.2011.21</ArticleId>
            <ArticleId IdType="pmc">PMC4437765</ArticleId>
            <ArticleId IdType="pubmed">21490621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yanai H, Chiba S, Hangai S, Kometani K, Inoue A, Kimura Y, Abe T, Kiyonari H, Nishio J, Taguchi-Atarashi N, et al.  (2018) Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice. Proc Natl Acad Sci U S A
115: 5253–5258. 10.1073/pnas.1803936115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1803936115</ArticleId>
            <ArticleId IdType="pmc">PMC5960330</ArticleId>
            <ArticleId IdType="pubmed">29712834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baird JR, Monjazeb AM, Shah O, McGee H, Murphy WJ, Crittenden MR, Gough MJ (2017) Stimulating innate immunity to enhance radiation therapy-induced tumor control. Int J Radiat Oncol Biol Phys
99: 362–373. 10.1016/j.ijrobp.2017.04.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijrobp.2017.04.014</ArticleId>
            <ArticleId IdType="pmc">PMC5604475</ArticleId>
            <ArticleId IdType="pubmed">28871985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruhland MK, Roberts EW, Cai E, Mujal AM, Marchuk K, Beppler C, Nam D, Serwas NK, Binnewies M, Krummel MF (2020) Visualizing synaptic transfer of tumor antigens among dendritic cells. Cancer Cell
37: 786–799.e5. 10.1016/j.ccell.2020.05.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2020.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC7671443</ArticleId>
            <ArticleId IdType="pubmed">32516589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR, Shortman K, Villadangos JA (2003) Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood
102: 2187–2194. 10.1182/blood-2003-02-0513</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2003-02-0513</ArticleId>
            <ArticleId IdType="pubmed">12791652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP (1992) Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med
176: 1215–1220. 10.1084/jem.176.4.1215</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.176.4.1215</ArticleId>
            <ArticleId IdType="pmc">PMC2119403</ArticleId>
            <ArticleId IdType="pubmed">1328465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, Li XD, Mauceri H, Beckett M, Darga T, et al.  (2014) STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity
41: 843–852. 10.1016/j.immuni.2014.10.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2014.10.019</ArticleId>
            <ArticleId IdType="pmc">PMC5155593</ArticleId>
            <ArticleId IdType="pubmed">25517616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harding SM, Benci JL, Irianto J, Discher DE, Minn AJ, Greenberg RA (2017) Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature
548: 466–470. 10.1038/nature23470</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature23470</ArticleId>
            <ArticleId IdType="pmc">PMC5857357</ArticleId>
            <ArticleId IdType="pubmed">28759889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruffell B, Chang-Strachan D, Chan V, Rosenbusch A, Ho CM, Pryer N, Daniel D, Hwang ES, Rugo HS, Coussens LM (2014) Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell
26: 623–637. 10.1016/j.ccell.2014.09.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2014.09.006</ArticleId>
            <ArticleId IdType="pmc">PMC4254570</ArticleId>
            <ArticleId IdType="pubmed">25446896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medler T, Patel JM, Alice A, Baird JR, Hu HM, Gough MJ (2019) Activating the nucleic acid-sensing machinery for anticancer immunity. Int Rev Cell Mol Biol
344: 173–214. 10.1016/bs.ircmb.2018.08.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.ircmb.2018.08.006</ArticleId>
            <ArticleId IdType="pmc">PMC6754183</ArticleId>
            <ArticleId IdType="pubmed">30798988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tormoen GW, Crittenden MR, Gough MJ (2018) Role of the immunosuppressive microenvironment in immunotherapy. Adv Radiat Oncol
3: 520–526. 10.1016/j.adro.2018.08.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.adro.2018.08.018</ArticleId>
            <ArticleId IdType="pmc">PMC6200899</ArticleId>
            <ArticleId IdType="pubmed">30370351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion. Nat Rev Cancer
21: 298–312. 10.1038/s41568-021-00339-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41568-021-00339-z</ArticleId>
            <ArticleId IdType="pubmed">33750922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villablanca EJ, Raccosta L, Zhou D, Fontana R, Maggioni D, Negro A, Sanvito F, Ponzoni M, Valentinis B, Bregni M, et al.  (2010) Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med
16: 98–105. 10.1038/nm.2074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2074</ArticleId>
            <ArticleId IdType="pubmed">20037595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baird JR, Friedman D, Cottam B, Dubensky TW Jr., Kanne DB, Bambina S, Bahjat K, Crittenden MR, Gough MJ (2016) Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors. Cancer Res
76: 50–61. 10.1158/0008-5472.CAN-14-3619</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-14-3619</ArticleId>
            <ArticleId IdType="pmc">PMC4703500</ArticleId>
            <ArticleId IdType="pubmed">26567136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin JH, Huffman AP, Wattenberg MM, Walter DM, Carpenter EL, Feldser DM, Beatty GL, Furth EE, Vonderheide RH (2020) Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis. J Exp Med
217: e20190673. 10.1084/jem.20190673</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20190673</ArticleId>
            <ArticleId IdType="pmc">PMC7398166</ArticleId>
            <ArticleId IdType="pubmed">32453421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wisdom AJ, Mowery YM, Hong CS, Himes JE, Nabet BY, Qin X, Zhang D, Chen L, Fradin H, Patel R, et al.  (2020) Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy. Nat Commun
11: 6410. 10.1038/s41467-020-19917-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-19917-0</ArticleId>
            <ArticleId IdType="pmc">PMC7746723</ArticleId>
            <ArticleId IdType="pubmed">33335088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchwald ZS, Nasti TH, Lee J, Eberhardt CS, Wieland A, Im SJ, Lawson D, Curran W, Ahmed R, Khan MK (2020) Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. J Immunother Cancer
8: e000867. 10.1136/jitc-2020-000867</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jitc-2020-000867</ArticleId>
            <ArticleId IdType="pmc">PMC7542667</ArticleId>
            <ArticleId IdType="pubmed">33028691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei J, Montalvo-Ortiz W, Yu L, Krasco A, Ebstein S, Cortez C, Lowy I, Murphy AJ, Sleeman MA, Skokos D (2021) Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses. Sci Immunol
6: eabg0117. 10.1126/sciimmunol.abg0117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/sciimmunol.abg0117</ArticleId>
            <ArticleId IdType="pubmed">33837124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edgar R, Domrachev M, Lash AE (2002) Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res
30: 207–210. 10.1093/nar/30.1.207</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/30.1.207</ArticleId>
            <ArticleId IdType="pmc">PMC99122</ArticleId>
            <ArticleId IdType="pubmed">11752295</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
